Results from a randomized, double‐blind, placebo‐controlled, crossover, multimodal‐MRI pilot study of gabapentin for co‐occurring bipolar and cannabis use disorders
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
Vol 159
◽
pp. 53-60
◽
Keyword(s):
2018 ◽
Vol 37
(5)
◽
pp. 416-423
◽
Keyword(s):